2-Acetyl-3,5-dimethylpyrazine
Common Name: |
2-Acetyl-3,5-dimethylpyrazine |
IUPAC Name: |
1-(3,5-dimethylpyrazin-2-yl)ethanone |
Molecular Formula: |
C8H10N2O |
SMILES: |
CC1=CN=C(C(=N1)C)C(=O)C |
Inchi: |
1S/C8H10N2O/c1-5-4-9-8(7(3)11)6(2)10-5/h4H,1-3H3 |
Inchi Key: |
UCGOSAWBWFUKDT-UHFFFAOYSA-N |
Cas No: |
54300-08-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
150.18 |
Mass (g/mol) |
150.079 |
Molar Refractivity |
42.16 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
42.85 |
Hetero Atoms |
3 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
70.00 @ 7.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
3 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.38 |
LogP |
1.296 |
iLOGP |
1.29 |
XLOGP3 |
0.60 |
WLOGP |
1.30 |
MLOGP |
-0.42 |
ESOL Log S |
-1.49 |
ESOL Solubility (mg/ml) |
4.9 |
ESOL Solubility (mol/l) |
0.033 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.07 |
Ali Solubility (mg/ml) |
12.7 |
Ali Solubility (mol/l) |
0.08 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.74 |
Silicos-IT Solubility (mg/ml) |
0.27 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.79 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.667 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.902 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |